Skip to main content

Headlines

Genmab Reports Positive Phase 1/2 Data For Rina-S In Resistant Ovarian Cancer
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Women Have a Powerful New Tool to See Their Risk of Breast Cancer, and It Works With an Existing Mammogram Image
posted:
by: Inc.
#channels:: #All, #Business, #Entrepreneur
Daiichi Sankyo, AstraZeneca, Summit Partner On Datroway- Ivonescimab Cancer Studies
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Cullinan's Zipalertinib Combination Heads To FDA After Positive Phase 3 Lung Cancer Trial
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
ZYUS Reports Trichomylin Shows Efficacy Signals In Cancer Pain Trial
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Roche Says Giredestrant- Everolimus Combo Significantly Improves PFS In ER+ Breast Cancer
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
AI 'Will Get Us Closer To Curing Cancer', Says Sen. Budd
posted:
by: Bloomberg Daybreak
#channels:: #All, #Business, #Bloomberg, #BloombergDaybreak, #Stocks
Silexion Doses First Patient In Phase 2/3 SIL204 Trial For Pancreatic Cancer
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Pyxis Prices $110 Mln Offering, With Potential Proceeds Of $282 Mln To Advance Lead Cancer Drug
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Veracyte's Decipher Test Predicts Hormone Therapy Benefit In Phase 3 Prostate Cancer Analysis
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
After losing his voice to cancer, this founder is building ‘glasses for voice’
posted:
by: TechCrunch
#channels:: #All, #News, #Technology, #Business, #TechCrunch
BeyondSpring Gets FDA Fast Track For Plinabulin In Lung Cancer
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
HUTCHMED Seeks FDA Approval For ORPATHYS-TAGRISSO In Resistant Lung Cancer
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
AstraZeneca Invests $2 Billion In Summit, Expands Cancer Drug Collaboration; Stock Up
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Oncolytics Nears Interim Data Update From Randomized REO 033 Colorectal Cancer Study
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks